TMC647055, a Potent Nonnucleoside Hepatitis C Virus NS5B Polymerase Inhibitor with Cross-Genotypic Coverage

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antimicrobial Agents and Chemotherapy 2012-09, Vol.56 (9), p.4676-4684
Hauptverfasser: DEVOGELAERE, Benoit, BERKE, Jan Martin, LENZ, Oliver, CUMMINGS, Maxwell D, CLAYTON, Reginald F, VENDEVILLE, Sandrine, RABOISSON, Pierre, SIMMEN, Kenneth A, FANNING, Gregory C, LIN, Tse-I, VIJGEN, Leen, DEHERTOGH, Pascale, FRANSEN, Els, CLEIREN, Erna, VAN DER HELM, Liesbet, NYANGUILE, Origène, TAHRI, Abdellah, AMSSOMS, Katie
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4684
container_issue 9
container_start_page 4676
container_title Antimicrobial Agents and Chemotherapy
container_volume 56
creator DEVOGELAERE, Benoit
BERKE, Jan Martin
LENZ, Oliver
CUMMINGS, Maxwell D
CLAYTON, Reginald F
VENDEVILLE, Sandrine
RABOISSON, Pierre
SIMMEN, Kenneth A
FANNING, Gregory C
LIN, Tse-I
VIJGEN, Leen
DEHERTOGH, Pascale
FRANSEN, Els
CLEIREN, Erna
VAN DER HELM, Liesbet
NYANGUILE, Origène
TAHRI, Abdellah
AMSSOMS, Katie
description Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       
doi_str_mv 10.1128/AAC.00245-12
format Article
fullrecord <record><control><sourceid>pubmed_highw</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3421868</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>22710121</sourcerecordid><originalsourceid>FETCH-LOGICAL-a474t-f7919895fd48b21e2c5445804ed33c637383ac778b3dacc88b83ebcce9b639323</originalsourceid><addsrcrecordid>eNp1kUtv1DAUhS0EokPLjjUyCxZITev3Y1NpiEpbqQ8kClvLcZyJSyYe2ZlW8-_rYUqBBaurq_v5XJ9zAXiH0RHGRB3P5_URQoTxCpMXYIaRVpXgWrwEM4SEqJhCbA-8yfkOlZ5r9BrsESIxwgTPwM_bq1owiTg_hBZ-jZMfJ3gdx3HtBh9zaD089ys7hSlkWMMfIa0zvP7GPxd22Cx9stnDi7EPTZhigg9h6mGdYs7VmR_jtFkFB-t4X7iFPwCvOjtk__ap7oPvX05v6_Pq8ubsop5fVpZJNlWd1FgrzbuWqYZgTxxnjBcXvqXUCSqpotZJqRraWueUahT1jXNeN4JqSug-ONnprtbN0reuWEp2MKsUljZtTLTB_DsZQ28W8d5QRrASqggc7gTc1kny3fNbjMw2dFNCN79CN3i779MOt3lJzF1cp7HY-x_7_u-_PQv_vkgBPj4BNjs7dMmOLuQ_nKCIYYkK92HH9WHRP4TkTdlurHWGC6MNE1LQR-h8oS0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>TMC647055, a Potent Nonnucleoside Hepatitis C Virus NS5B Polymerase Inhibitor with Cross-Genotypic Coverage</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>DEVOGELAERE, Benoit ; BERKE, Jan Martin ; LENZ, Oliver ; CUMMINGS, Maxwell D ; CLAYTON, Reginald F ; VENDEVILLE, Sandrine ; RABOISSON, Pierre ; SIMMEN, Kenneth A ; FANNING, Gregory C ; LIN, Tse-I ; VIJGEN, Leen ; DEHERTOGH, Pascale ; FRANSEN, Els ; CLEIREN, Erna ; VAN DER HELM, Liesbet ; NYANGUILE, Origène ; TAHRI, Abdellah ; AMSSOMS, Katie</creator><creatorcontrib>DEVOGELAERE, Benoit ; BERKE, Jan Martin ; LENZ, Oliver ; CUMMINGS, Maxwell D ; CLAYTON, Reginald F ; VENDEVILLE, Sandrine ; RABOISSON, Pierre ; SIMMEN, Kenneth A ; FANNING, Gregory C ; LIN, Tse-I ; VIJGEN, Leen ; DEHERTOGH, Pascale ; FRANSEN, Els ; CLEIREN, Erna ; VAN DER HELM, Liesbet ; NYANGUILE, Origène ; TAHRI, Abdellah ; AMSSOMS, Katie</creatorcontrib><description>Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions &amp; Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       </description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/AAC.00245-12</identifier><identifier>PMID: 22710121</identifier><identifier>CODEN: AACHAX</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral Agents ; Antiviral Agents - pharmacology ; Biological and medical sciences ; Cell Line ; Cloning, Molecular ; Drug Combinations ; Drug Synergism ; Enzyme Inhibitors ; Enzyme Inhibitors - pharmacology ; Escherichia coli - genetics ; Genes, Reporter ; Hepacivirus ; Hepacivirus - drug effects ; Hepacivirus - enzymology ; Hepacivirus - genetics ; Hepacivirus - growth &amp; development ; Hepatitis C, Chronic - drug therapy ; Hepatitis C, Chronic - virology ; Heterocyclic Compounds, 4 or More Rings ; Heterocyclic Compounds, 4 or More Rings - pharmacology ; Human viral diseases ; Humans ; Infectious diseases ; Medical sciences ; Pharmacology. Drug treatments ; Plasmids ; Recombinant Proteins - antagonists &amp; inhibitors ; Recombinant Proteins - metabolism ; RNA Replicase ; RNA-Dependent RNA Polymerase - antagonists &amp; inhibitors ; RNA-Dependent RNA Polymerase - metabolism ; Sulfonamides ; Sulfonamides - pharmacology ; Transfection ; Viral diseases ; Viral hepatitis ; Viral Nonstructural Proteins ; Viral Nonstructural Proteins - antagonists &amp; inhibitors ; Viral Nonstructural Proteins - metabolism ; Virus Replication - drug effects</subject><ispartof>Antimicrobial Agents and Chemotherapy, 2012-09, Vol.56 (9), p.4676-4684</ispartof><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012, American Society for Microbiology. All Rights Reserved.</rights><rights>Copyright © 2012, American Society for Microbiology. All Rights Reserved. 2012 American Society for Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a474t-f7919895fd48b21e2c5445804ed33c637383ac778b3dacc88b83ebcce9b639323</citedby><cites>FETCH-LOGICAL-a474t-f7919895fd48b21e2c5445804ed33c637383ac778b3dacc88b83ebcce9b639323</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3421868/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3421868/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=26304170$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22710121$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DEVOGELAERE, Benoit</creatorcontrib><creatorcontrib>BERKE, Jan Martin</creatorcontrib><creatorcontrib>LENZ, Oliver</creatorcontrib><creatorcontrib>CUMMINGS, Maxwell D</creatorcontrib><creatorcontrib>CLAYTON, Reginald F</creatorcontrib><creatorcontrib>VENDEVILLE, Sandrine</creatorcontrib><creatorcontrib>RABOISSON, Pierre</creatorcontrib><creatorcontrib>SIMMEN, Kenneth A</creatorcontrib><creatorcontrib>FANNING, Gregory C</creatorcontrib><creatorcontrib>LIN, Tse-I</creatorcontrib><creatorcontrib>VIJGEN, Leen</creatorcontrib><creatorcontrib>DEHERTOGH, Pascale</creatorcontrib><creatorcontrib>FRANSEN, Els</creatorcontrib><creatorcontrib>CLEIREN, Erna</creatorcontrib><creatorcontrib>VAN DER HELM, Liesbet</creatorcontrib><creatorcontrib>NYANGUILE, Origène</creatorcontrib><creatorcontrib>TAHRI, Abdellah</creatorcontrib><creatorcontrib>AMSSOMS, Katie</creatorcontrib><title>TMC647055, a Potent Nonnucleoside Hepatitis C Virus NS5B Polymerase Inhibitor with Cross-Genotypic Coverage</title><title>Antimicrobial Agents and Chemotherapy</title><addtitle>Antimicrob Agents Chemother</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions &amp; Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       </description><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiviral Agents</subject><subject>Antiviral Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Cell Line</subject><subject>Cloning, Molecular</subject><subject>Drug Combinations</subject><subject>Drug Synergism</subject><subject>Enzyme Inhibitors</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Escherichia coli - genetics</subject><subject>Genes, Reporter</subject><subject>Hepacivirus</subject><subject>Hepacivirus - drug effects</subject><subject>Hepacivirus - enzymology</subject><subject>Hepacivirus - genetics</subject><subject>Hepacivirus - growth &amp; development</subject><subject>Hepatitis C, Chronic - drug therapy</subject><subject>Hepatitis C, Chronic - virology</subject><subject>Heterocyclic Compounds, 4 or More Rings</subject><subject>Heterocyclic Compounds, 4 or More Rings - pharmacology</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Plasmids</subject><subject>Recombinant Proteins - antagonists &amp; inhibitors</subject><subject>Recombinant Proteins - metabolism</subject><subject>RNA Replicase</subject><subject>RNA-Dependent RNA Polymerase - antagonists &amp; inhibitors</subject><subject>RNA-Dependent RNA Polymerase - metabolism</subject><subject>Sulfonamides</subject><subject>Sulfonamides - pharmacology</subject><subject>Transfection</subject><subject>Viral diseases</subject><subject>Viral hepatitis</subject><subject>Viral Nonstructural Proteins</subject><subject>Viral Nonstructural Proteins - antagonists &amp; inhibitors</subject><subject>Viral Nonstructural Proteins - metabolism</subject><subject>Virus Replication - drug effects</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kUtv1DAUhS0EokPLjjUyCxZITev3Y1NpiEpbqQ8kClvLcZyJSyYe2ZlW8-_rYUqBBaurq_v5XJ9zAXiH0RHGRB3P5_URQoTxCpMXYIaRVpXgWrwEM4SEqJhCbA-8yfkOlZ5r9BrsESIxwgTPwM_bq1owiTg_hBZ-jZMfJ3gdx3HtBh9zaD089ys7hSlkWMMfIa0zvP7GPxd22Cx9stnDi7EPTZhigg9h6mGdYs7VmR_jtFkFB-t4X7iFPwCvOjtk__ap7oPvX05v6_Pq8ubsop5fVpZJNlWd1FgrzbuWqYZgTxxnjBcXvqXUCSqpotZJqRraWueUahT1jXNeN4JqSug-ONnprtbN0reuWEp2MKsUljZtTLTB_DsZQ28W8d5QRrASqggc7gTc1kny3fNbjMw2dFNCN79CN3i779MOt3lJzF1cp7HY-x_7_u-_PQv_vkgBPj4BNjs7dMmOLuQ_nKCIYYkK92HH9WHRP4TkTdlurHWGC6MNE1LQR-h8oS0</recordid><startdate>20120901</startdate><enddate>20120901</enddate><creator>DEVOGELAERE, Benoit</creator><creator>BERKE, Jan Martin</creator><creator>LENZ, Oliver</creator><creator>CUMMINGS, Maxwell D</creator><creator>CLAYTON, Reginald F</creator><creator>VENDEVILLE, Sandrine</creator><creator>RABOISSON, Pierre</creator><creator>SIMMEN, Kenneth A</creator><creator>FANNING, Gregory C</creator><creator>LIN, Tse-I</creator><creator>VIJGEN, Leen</creator><creator>DEHERTOGH, Pascale</creator><creator>FRANSEN, Els</creator><creator>CLEIREN, Erna</creator><creator>VAN DER HELM, Liesbet</creator><creator>NYANGUILE, Origène</creator><creator>TAHRI, Abdellah</creator><creator>AMSSOMS, Katie</creator><general>American Society for Microbiology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20120901</creationdate><title>TMC647055, a Potent Nonnucleoside Hepatitis C Virus NS5B Polymerase Inhibitor with Cross-Genotypic Coverage</title><author>DEVOGELAERE, Benoit ; BERKE, Jan Martin ; LENZ, Oliver ; CUMMINGS, Maxwell D ; CLAYTON, Reginald F ; VENDEVILLE, Sandrine ; RABOISSON, Pierre ; SIMMEN, Kenneth A ; FANNING, Gregory C ; LIN, Tse-I ; VIJGEN, Leen ; DEHERTOGH, Pascale ; FRANSEN, Els ; CLEIREN, Erna ; VAN DER HELM, Liesbet ; NYANGUILE, Origène ; TAHRI, Abdellah ; AMSSOMS, Katie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a474t-f7919895fd48b21e2c5445804ed33c637383ac778b3dacc88b83ebcce9b639323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiviral Agents</topic><topic>Antiviral Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Cell Line</topic><topic>Cloning, Molecular</topic><topic>Drug Combinations</topic><topic>Drug Synergism</topic><topic>Enzyme Inhibitors</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Escherichia coli - genetics</topic><topic>Genes, Reporter</topic><topic>Hepacivirus</topic><topic>Hepacivirus - drug effects</topic><topic>Hepacivirus - enzymology</topic><topic>Hepacivirus - genetics</topic><topic>Hepacivirus - growth &amp; development</topic><topic>Hepatitis C, Chronic - drug therapy</topic><topic>Hepatitis C, Chronic - virology</topic><topic>Heterocyclic Compounds, 4 or More Rings</topic><topic>Heterocyclic Compounds, 4 or More Rings - pharmacology</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Plasmids</topic><topic>Recombinant Proteins - antagonists &amp; inhibitors</topic><topic>Recombinant Proteins - metabolism</topic><topic>RNA Replicase</topic><topic>RNA-Dependent RNA Polymerase - antagonists &amp; inhibitors</topic><topic>RNA-Dependent RNA Polymerase - metabolism</topic><topic>Sulfonamides</topic><topic>Sulfonamides - pharmacology</topic><topic>Transfection</topic><topic>Viral diseases</topic><topic>Viral hepatitis</topic><topic>Viral Nonstructural Proteins</topic><topic>Viral Nonstructural Proteins - antagonists &amp; inhibitors</topic><topic>Viral Nonstructural Proteins - metabolism</topic><topic>Virus Replication - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DEVOGELAERE, Benoit</creatorcontrib><creatorcontrib>BERKE, Jan Martin</creatorcontrib><creatorcontrib>LENZ, Oliver</creatorcontrib><creatorcontrib>CUMMINGS, Maxwell D</creatorcontrib><creatorcontrib>CLAYTON, Reginald F</creatorcontrib><creatorcontrib>VENDEVILLE, Sandrine</creatorcontrib><creatorcontrib>RABOISSON, Pierre</creatorcontrib><creatorcontrib>SIMMEN, Kenneth A</creatorcontrib><creatorcontrib>FANNING, Gregory C</creatorcontrib><creatorcontrib>LIN, Tse-I</creatorcontrib><creatorcontrib>VIJGEN, Leen</creatorcontrib><creatorcontrib>DEHERTOGH, Pascale</creatorcontrib><creatorcontrib>FRANSEN, Els</creatorcontrib><creatorcontrib>CLEIREN, Erna</creatorcontrib><creatorcontrib>VAN DER HELM, Liesbet</creatorcontrib><creatorcontrib>NYANGUILE, Origène</creatorcontrib><creatorcontrib>TAHRI, Abdellah</creatorcontrib><creatorcontrib>AMSSOMS, Katie</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial Agents and Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DEVOGELAERE, Benoit</au><au>BERKE, Jan Martin</au><au>LENZ, Oliver</au><au>CUMMINGS, Maxwell D</au><au>CLAYTON, Reginald F</au><au>VENDEVILLE, Sandrine</au><au>RABOISSON, Pierre</au><au>SIMMEN, Kenneth A</au><au>FANNING, Gregory C</au><au>LIN, Tse-I</au><au>VIJGEN, Leen</au><au>DEHERTOGH, Pascale</au><au>FRANSEN, Els</au><au>CLEIREN, Erna</au><au>VAN DER HELM, Liesbet</au><au>NYANGUILE, Origène</au><au>TAHRI, Abdellah</au><au>AMSSOMS, Katie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>TMC647055, a Potent Nonnucleoside Hepatitis C Virus NS5B Polymerase Inhibitor with Cross-Genotypic Coverage</atitle><jtitle>Antimicrobial Agents and Chemotherapy</jtitle><stitle>Antimicrob Agents Chemother</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>2012-09-01</date><risdate>2012</risdate><volume>56</volume><issue>9</issue><spage>4676</spage><epage>4684</epage><pages>4676-4684</pages><issn>0066-4804</issn><eissn>1098-6596</eissn><coden>AACHAX</coden><abstract>Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions &amp; Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       </abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>22710121</pmid><doi>10.1128/AAC.00245-12</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0066-4804
ispartof Antimicrobial Agents and Chemotherapy, 2012-09, Vol.56 (9), p.4676-4684
issn 0066-4804
1098-6596
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3421868
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Antibiotics. Antiinfectious agents. Antiparasitic agents
Antiviral Agents
Antiviral Agents - pharmacology
Biological and medical sciences
Cell Line
Cloning, Molecular
Drug Combinations
Drug Synergism
Enzyme Inhibitors
Enzyme Inhibitors - pharmacology
Escherichia coli - genetics
Genes, Reporter
Hepacivirus
Hepacivirus - drug effects
Hepacivirus - enzymology
Hepacivirus - genetics
Hepacivirus - growth & development
Hepatitis C, Chronic - drug therapy
Hepatitis C, Chronic - virology
Heterocyclic Compounds, 4 or More Rings
Heterocyclic Compounds, 4 or More Rings - pharmacology
Human viral diseases
Humans
Infectious diseases
Medical sciences
Pharmacology. Drug treatments
Plasmids
Recombinant Proteins - antagonists & inhibitors
Recombinant Proteins - metabolism
RNA Replicase
RNA-Dependent RNA Polymerase - antagonists & inhibitors
RNA-Dependent RNA Polymerase - metabolism
Sulfonamides
Sulfonamides - pharmacology
Transfection
Viral diseases
Viral hepatitis
Viral Nonstructural Proteins
Viral Nonstructural Proteins - antagonists & inhibitors
Viral Nonstructural Proteins - metabolism
Virus Replication - drug effects
title TMC647055, a Potent Nonnucleoside Hepatitis C Virus NS5B Polymerase Inhibitor with Cross-Genotypic Coverage
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T10%3A28%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_highw&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=TMC647055,%20a%20Potent%20Nonnucleoside%20Hepatitis%20C%20Virus%20NS5B%20Polymerase%20Inhibitor%20with%20Cross-Genotypic%20Coverage&rft.jtitle=Antimicrobial%20Agents%20and%20Chemotherapy&rft.au=DEVOGELAERE,%20Benoit&rft.date=2012-09-01&rft.volume=56&rft.issue=9&rft.spage=4676&rft.epage=4684&rft.pages=4676-4684&rft.issn=0066-4804&rft.eissn=1098-6596&rft.coden=AACHAX&rft_id=info:doi/10.1128/AAC.00245-12&rft_dat=%3Cpubmed_highw%3E22710121%3C/pubmed_highw%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/22710121&rfr_iscdi=true